PAREXEL International Announces Date of Second Quarter Fiscal Year 2016 Earnings Release and Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter Fiscal Year 2016 on Wednesday, January 27th, 2016 after the close of the stock market.

PAREXEL will host a conference call and live webcast at 10:00 a.m. ET on Thursday, January 28th, 2016 to discuss the results. To access the webcast, visit the Investor Section of PAREXEL’s website at www.PAREXEL.com. This webcast will continue to be accessible for one year following the live broadcast. To participate via telephone, dial [phone] and ask to join PAREXEL’s Second Quarter Fiscal Year 2016 conference call.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 80 locations in 51 countries around the world, and had approximately 18,620 employees in the first quarter. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151221005038/en/

PAREXEL International CorporationIngo Bank, Senior Vice President and Chief Financial OfficerInvestor Relations, +1 [e-mail]